News
Hospitals refused to give patients ivermectin. Lockdowns and political pressure followed.
December 3, 2021
“My patient was struggling to breathe, but the family refused to allow me to provide care. A call to the police was the only solution.”
![1]()
News
No serious CV risks for elderly after Pfizer COVID-19 vaccine
December 2, 2021
A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events in elderly individuals.
News
COVID-19 antibody drug likely works against Omicron, companies say
December 2, 2021
The preliminary findings haven’t yet been peer-reviewed.
News
Rituximab likely raises risk of hospital death in COVID-19 patients
December 2, 2021
In a retrospective study of hospitalized COVID-19 patients, “only 1 of 303 drugs examined, rituximab, was associated with an increased risk of in-hospital death ... both when used for rheumatologic as well as for cancer therapy.”
News
EXPLAINER-Does omicron pose higher risks for infants than other variants?
December 2, 2021
Asked whether people should be alarmed by the infant admissions numbers, Professor Anne von Gottberg told Reuters: “Not yet.”
![1]()
News
Ten changes that could keep clinicians in the workforce in a pandemic
December 2, 2021
Doctors make checklist of low-cost action items to start addressing a wave of providers leaving medicine.
News
Second U.S. COVID-19 case caused by Omicron found
December 2, 2021
“This news is concerning, but it is not a surprise.”
![1]()
News
SGLT2 inhibitor use tied to fewer atrial arrhythmias
December 2, 2021
A prospective study of nearly 14,000 patients who received an implantable cardiac device suggests that SGLT2-inhibitor treatment cuts atrial arrhythmias.
News
First Omicron variant case identified in U.S.
December 1, 2021
“All close contacts have been contacted and have tested negative.”
News
Moderna warns of material drop in vaccine efficacy against Omicron
December 1, 2021
“There is no world, I think, where [the effectiveness] is the same level … we had with Delta.”
